Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05328271 · ClinicalTrials.gov registry record · NA
A Pilot Study to Determine the Bioavailability of Oral Beta-Aminoisobutyric Acid (BAIBA) Ingestion
A NA study, sponsored by Lindenwood University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05328271 is a NA study that has completed, run by Lindenwood University. The registered enrollment target is 12 participants.
The verdict
NCT05328271, a NA study, has completed, sponsored by Lindenwood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Think of this section as your research "elevator pitch." Please briefly describe the question(s) or issues you are addressing with your research (limited to 100 words). You will be able to provide information on specific outcomes, hypothesis, or related analysis in a following question. Beta-amino isobutyric acid (BAIBA) is a myokine produced in skeletal muscle and has been shown to impact how our body metabolizes fuel. We seek to determine the bioavailability of different doses of orally ingested beta-aminoisobutyric acid (BAIBA).
Interventions
- DIETARY_SUPPLEMENT Beta-Aminoisobutyric Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2022-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05328271
The ClinicalTrials.gov registry entry for NCT05328271 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Beta-Aminoisobutyric Acid is the first listed.
NCT05328271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05328271 about?
NCT05328271 is a clinical study titled "A Pilot Study to Determine the Bioavailability of Oral Beta-Aminoisobutyric Acid (BAIBA) Ingestion". Think of this section as your research "elevator pitch." Please briefly describe the question(s) or issues you are addressing with your research (limited to 100 words). You will be able to provide information on specific outcomes, hypothesis, or related analysis in a following question. Beta-amino ...
What is the current status of trial NCT05328271?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-11-20. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT05328271?
The interventions under investigation include: Beta-Aminoisobutyric Acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05328271?
This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.